Detalhe da pesquisa
1.
16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.
Eur Heart J
; 41(7): 847-854, 2020 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504424
2.
Diabetes Mellitus Is Associated With Increased Risk of Ischemic Stroke in Patients With and Without Coronary Artery Disease.
Stroke
; 50(12): 3347-3354, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31690249
3.
Diabetes and Coronary Artery Disease as Risk Factors for Dementia.
Eur J Prev Cardiol
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38680097
4.
Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation.
Eur Heart J Cardiovasc Pharmacother
; 9(3): 208-219, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36269306
5.
Twenty-Year Temporal Trends in Risk of Ischemic Stroke in Incident Type 2 Diabetes: A Danish Population-Based Cohort Study.
Diabetes Care
; 45(9): 2144-2151, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35876649
6.
Diabetes is not a risk factor for myocardial infarction in patients without coronary artery disease: A study from the Western Denmark Heart Registry.
Diab Vasc Dis Res
; 17(4): 1479164120941809, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32722933
7.
Eligibility for and Preventive Potential of Semaglutide in Overweight and Obese Patients With Myocardial Infarction.
J Am Coll Cardiol
; 83(9): 956-958, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418010